And Just Like That, We Have Another Double. iBio (IBIO).

$5.35 With 11 Million Shares Traded and it's Not Even 10:00!
Immuron, Biotech Stock Review

Immuron (IMRN) to Bank $20 Million.

Another Corona Virus Mania Makes Bank. This time $20 million into Immuron which once struggled, when it was trading near $2.00 just...

SEC Charges Microcap Fraud Scheme Participants Attempting to Capitalize on the COVID-19 Pandemic.

FOR IMMEDIATE RELEASE2020-131 Washington D.C., June 11, 2020 — The Securities and...

2020 Biotech Portfolio Soars 55%, We’re Amazed. Next Up: The Coming Gold Rush.

1. Yep, We Are Absolutely Amazed At The Biotech Stock Review's 2020 Watch List Performance – Especially In The Light Of...
Alpex BioCleanse, Biotech Stock Review

Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now Publicly Traded!

Sunset Capital Assets, Inc., (SNST), Executes and Completes Definitive Share Exchange Agreement with Aphex BioCleanse Systems Inc. Our favorite...
citius pharma, biotech stock review

Investors Bet $8 Million on Citius Pharma (CTXR) $1.10, Succeeding in FDA Trials!

Great headline, right? The actual headline was: Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million

Does Co-Diagnostics (CODX) Have Ties to Offshore Boiler Rooms?

Hot Covid-19 test company has ties to offshore boiler rooms (SharesSleuth.com) AKA, you'd have to have your head examined...
Biotech Stock Review, Aphex BioCLeanse

Adding Aphex BioCleanse Systems (SNST) to CoronaVirus Watch List.

Former Eastman Kodak Scientist Engineers Develop Liquid Germ Killer Hy-IQ™ Water to Revolutionize how Deadly Bacteria and Virus are Eradicated

Clorox and P&G Struggle to Meet COVID-19-Related Spike in Demand (MarketWatch).

Clorox shares have soared more than 54% for the year to date, an increase of $11.5 billion to $29.5 billion.

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!